InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,220.71
(
-0.04%
)
US TECH 100
17,715.60
(
0.19%
)
Dow Jones
39,442.44
(
-0.18%
)
Brent Oil
83.26
(
1.06%
)
Bitcoin
62,705.42
(
2.05%
)
Post# of 251806
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119625
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 164591

Tuesday, 09/10/2013 1:25:57 PM

Tuesday, September 10, 2013 1:25:57 PM

Post# of 251806
ABBV/ENTA plan to run a Japanese phase-3 trial of ABT-450/r + ABT-267 without ribavirin in GT1b treatment-naïve patients. (Source: ABBV webcast at Morgan Stanley that just finished.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up